Quantitative Analysis of Next-Generation Immunosuppressants in Whole Blood Using High-Throughput LC-MS/MS:

Mass spectrometry has established itself as a cornerstone of the modern clinical laboratory, particularly in the realm of therapeutic drug monitoring and the identification of complex metabolic disorders. This study presents a comprehensive evaluation of a novel high-throughput liquid chromatography-tandem mass spectrometry (LC-MS/MS) method designed for the rapid quantification of steroid profiles in human serum. By optimizing sample preparation through automated solid-phase extraction and utilizing a high-resolution orbital ion trap system, we achieved significant improvements in analytical sensitivity and turnaround time compared to traditional immunoassay techniques. Our results demonstrate that the proposed workflow effectively mitigates common matrix interferences while maintaining a broad dynamic range and exceptional precision across multi-day validation runs. The implementation of this methodology in a high-volume clinical setting suggests a viable path toward increasing diagnostic accuracy and improving patient outcomes through more rigorous biochemical phenotyping. These findings underscore the ongoing transition toward mass spectrometry as the primary platform for specialized clinical assays where analytical specificity is paramount.